Premium
A case of cutaneous pseudolymphoma with a distinctive appearance treated successfully by intralesional interferon alpha‐1b and corticosteroids
Author(s) -
Zeng Shihua,
Chen Siyu,
Tang Xinyue,
Wang Lin
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13410
Subject(s) - medicine , betamethasone , pseudolymphoma , alpha interferon , betamethasone dipropionate , dermatology , pathogenesis , pathological , interferon alfa , pathology , interferon , lymphoma , immunology
Cutaneous pseudolymphoma (CPL) encompasses various forms of benign lymphocytic proliferative dermatoses that mimic the clinical and/or pathological changes of lymphoma. The clinical manifestations of CPL vary due to differences in the pathogenesis, and accordingly, no specific treatment has been identified. Here, we report a case of CPL on the nose, which had a distinctive appearance and was treated successfully using a combination of intralesional interferon alpha‐1b and compound betamethasone (betamethasone sodium phosphate and betamethasone dipropionate). This combination may be a good option for localized CPLs at particular anatomical sites.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom